What is the Projected CAGR value of the Pseudomonas Aeruginosa Infection Treatment Market?
The Pseudomonas Aeruginosa Infection Treatment Market is expected to grow at a CAGR of 5.4% during the forecasting period 2023-2030.
Who are the Key Players of Pseudomonas Aeruginosa Infection Treatment Market ?
Some of the key players which are contributing to the growth of the market include; AbbVie Inc. (Allergan plc), Teva Pharmaceutical Industries Ltd, Pfizer, Inc, Merck & Co., Inc, AstraZeneca, Bristol-Myers Squibb Co, Lupin Pharmaceuticals, Inc, Janssen Pharmaceuticals, Inc, Gilead Sciences Inc, and Novartis AG.